Author
Zoë YGJ van Lierop
Also Known As
Z.Y.G. van Lierop, Z.Y.G.J. van Lierop, ZYGJ van Lierop, Zoë Y. G. J. van Lierop, Zoë Y.G. van Lierop, Zoë Y.G.J. Van Lierop, Zoë YGJ Van Lierop, Zoë YGJ van Lierop, Zoë Yolanthe Germieke Jocelyn van Lierop, Zoë Y.G.J. van Lierop
16
Publications
312
Citations
10
H-Index
15
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 2 | 2 | 37 |
2 | Immunology | 2 | 2 | 37 |
3 | Public Health | 1 | 1 | 15 |
4 | Neurology | 1 | 1 | 22 |
5 | Pathology | 1 | 1 | 22 |
Zoë YGJ van Lierop
×
10
Publications
282
Citations
10
H-Index
| Year | Citations | |
|---|---|---|
2021 | 66 | |
2022 | 51 | |
2023 | 32 | |
2021 | 26 | |
2020 | 25 | |
2021 | 22 | |
2021 | 17 | |
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients Zoë YGJ van Lierop, EME Coerver, Eaj Willemse, Multiple Sclerosis Journal - Experimental Translational and Clinical Multiple Sclerosis PatientsIndirect SwitchAutoimmune DiseaseDisease ProgressionViral Persistence | 2021 | 15 |
2023 | 15 | |
2023 | 13 |
Page 1
Page 1